Bayer AG
BAYRY
Company Profile
- Business description- Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm's crop science business sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto. 
- Contact- Kaiser-Wilhelm-Allee 1 
 LeverkusenNW51368
 DEU- T: +49 214301 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Drug Manufacturers - General - Fiscal Year End- 31 December 2025 - Employees- 90,885 
Bayer AG News & Analysis
stocks
10 global stocks for a recession
These undervalued stocks come from high-quality companies in defensive sectors.
stocks
10 bargain, high-quality global equities
Chinese tech giants SINA and Tencent join Canadian uranium miner Cameco at the top of our list of international stocks trading at steep discounts to our fair value estimates.
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,178.00 | 28.70 | -0.31% | 
| CAC 40 | 8,121.07 | 79.81 | -0.97% | 
| DAX 40 | 23,958.30 | 160.59 | -0.67% | 
| Dow JONES (US) | 47,562.87 | 40.75 | 0.09% | 
| FTSE 100 | 9,717.25 | 42.81 | -0.44% | 
| HKSE | 25,906.65 | 376.04 | -1.43% | 
| NASDAQ | 23,724.96 | 143.81 | 0.61% | 
| Nikkei 225 | 52,411.34 | 1,085.73 | 2.12% | 
| NZX 50 Index | 13,548.32 | 89.03 | 0.66% | 
| S&P 500 | 6,840.20 | 17.86 | 0.26% | 
| S&P/ASX 200 | 8,881.90 | 31.30 | -0.35% | 
| SSE Composite Index | 3,954.79 | 32.11 | -0.81% |